FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

421637006: Lyophilized powder for conventional release solution for injection (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3636025015 Lyophilized powder for conventional release solution for injection (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636026019 Lyophilised powder for conventional release solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636027011 Lyophilized powder for conventional release solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636028018 Lyophilized powder for solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636029014 Lyophilised powder for solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lyophilized powder for conventional release solution for injection (dose form) Is a Powder for solution for injection true Inferred relationship Some
Lyophilized powder for conventional release solution for injection (dose form) Has dose form administration method (attribute) Inject (administration method) true Inferred relationship Some
Lyophilized powder for conventional release solution for injection (dose form) Has dose form transformation (attribute) Dissolve (transformation) true Inferred relationship Some
Lyophilized powder for conventional release solution for injection (dose form) Has dose form intended site (attribute) Parenteral (intended site) true Inferred relationship Some
Lyophilized powder for conventional release solution for injection (dose form) Has dose form release characteristic (attribute) Conventional release (release characteristic) true Inferred relationship Some
Lyophilized powder for conventional release solution for injection (dose form) Is a Parenteral dose form (dose form) false Inferred relationship Some
Lyophilized powder for conventional release solution for injection (dose form) Has basic dose form (attribute) Lyophilized powder (basic dose form) true Inferred relationship Some
Lyophilized powder for conventional release solution for injection (dose form) Is a Lyophilized powder for conventional release solution for infusion and/or injection (dose form) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Velaglucerase alfa 200unit lyophilized powder for injection solution Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely belimumab 400 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely belimumab 120 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Canakinumab 150mg powder for injection solution Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely human immunoglobulin G 6 gram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely octocog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely octocog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely onabotulinumtoxinA 100 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely lurbinectedin 4 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely remimazolam (as remimazolam besylate) 20 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely Clostridium histolyticum collagenase 900 microgram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some
Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection (dose form) Inferred relationship Some

This concept is not in any reference sets

Back to Start